Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JAXKUBOR. The owner is based in Guangzhou.
Room 1716, No. 10 Lixiang Road, Huangpu District,
Guangzhou 510700 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. have?
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. file in?
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd.'s most well-known trademarks?
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as JAXKUBOR. These are among 1 currently registered trademark in the portfolio.
What is Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd.'s trademark registration success rate?
Guangzhou Yuanqi Yuedong Medical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.